How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants

How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants

How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants

In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek® Flow® software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.

Agenda:

  • Align and filter whole exome sequencing data
  • Detect variants from tumor and cell-free DNA
  • Perform annotation and filtering to prioritize variants

Webinar On-Demand Form
Please enter a company/institutional email address.
Share this post:
tbmanelaHow to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants